The effects of a sustained-release recombinant bovine somatotropin (somidobove) on udder health for a full lactation
The lactational effect of somidobove (recombinant bST) injections on dairy cows in a full lactation was measured in 193 primiparous and 159 multiparous Holsteins. Experimental animals, distributed across six study sites, were administered a sustained-release formulation of somidobove by subcutaneous...
Gespeichert in:
| Veröffentlicht in: | Journal of dairy science 1994-08, Vol.77 (8), p.2261-2271 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2271 |
|---|---|
| container_issue | 8 |
| container_start_page | 2261 |
| container_title | Journal of dairy science |
| container_volume | 77 |
| creator | McClary, D.G Green, H.B Basson, R.P Nickerson, S.C |
| description | The lactational effect of somidobove (recombinant bST) injections on dairy cows in a full lactation was measured in 193 primiparous and 159 multiparous Holsteins. Experimental animals, distributed across six study sites, were administered a sustained-release formulation of somidobove by subcutaneous injection every 28 d beginning 36 to 49 DIM. Randomization at each site determined which of the following somidobove treatments cows received: 0 mg (control), 160 mg (primiparous only), 320 mg, 640 mg, or 960 mg (multiparous only). In addition to lactation response, cows on study were monitored for mastitis. Clinical mastitis was detected by examination of quarter foremilk at each milking. Milk from 300 of 352 cows was monitored for new IMI by routine collection and culture of duplicate quarter milk samples. Somatic cell counts were conducted on individual composite milk samples collected weekly throughout the experiment. No evidence existed of an association between somidobove administration and the incidence or duration of clinical mastitis. Furthermore, somidobove administration was not associated with an increase in new IMI or prevalence of infection by common mastitis pathogens or pathogen groups. Somatic cell counts were low in all treatment groups, but a dose-related trend was found for increased SCC in both primiparous and multiparous cows |
| doi_str_mv | 10.3168/jds.S0022-0302(94)77169-1 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76817491</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76817491</sourcerecordid><originalsourceid>FETCH-LOGICAL-c470t-bf51595f3052a568cc598caa87443e02db29c9f4ec820bd83d4fb71c6c76705f3</originalsourceid><addsrcrecordid>eNpdkV1rFDEYhQdR6lr9A4IQUaS9mJpkJl-XUvyCghdtr8M7maSbJTNZk4zivzfTXVbwKrycJ-ck72matwRfdYTLj7sxX91iTGmLO0wvVH8pBOGqJU-aDWGUtR1R8mmzOSHPmxc57-pIKGZnzZlQnMpebppyt7XIOmdNySg6BCgvuYCf7dgmGyxki5I1cRr8DHNBQ_xVNZTjBCWWFPd-Rhd18mOskr1EcUbLONqEthZC2SIXUzV1SwgogClQfJxfNs8chGxfHc_z5v7L57vrb-3Nj6_frz_dtKYXuLSDY4Qp5jrMKDAujWFKGgAp-r6zmI4DVUa53hpJ8TDKbuzdIIjhRnCB673z5sPBd5_iz8XmoiefjQ0BZhuXrAWXRPSKVPDdf-AuLmmub9NE1tUShQWvlDpQJsWck3V6n_wE6Y8mWK-96NqLfuxFr0vXqtePveg14c0xYRkmO55uHouo-vujDtlAcAlm4_MJ6zoqicT_frT1D9vfPlmdJwihmpI1XAgtNaV8zXt9AB1EDQ-pet3fKkZ4XWb3F-D4rNs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1877119076</pqid></control><display><type>article</type><title>The effects of a sustained-release recombinant bovine somatotropin (somidobove) on udder health for a full lactation</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><source>Periodicals Index Online</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>McClary, D.G ; Green, H.B ; Basson, R.P ; Nickerson, S.C</creator><creatorcontrib>McClary, D.G ; Green, H.B ; Basson, R.P ; Nickerson, S.C</creatorcontrib><description>The lactational effect of somidobove (recombinant bST) injections on dairy cows in a full lactation was measured in 193 primiparous and 159 multiparous Holsteins. Experimental animals, distributed across six study sites, were administered a sustained-release formulation of somidobove by subcutaneous injection every 28 d beginning 36 to 49 DIM. Randomization at each site determined which of the following somidobove treatments cows received: 0 mg (control), 160 mg (primiparous only), 320 mg, 640 mg, or 960 mg (multiparous only). In addition to lactation response, cows on study were monitored for mastitis. Clinical mastitis was detected by examination of quarter foremilk at each milking. Milk from 300 of 352 cows was monitored for new IMI by routine collection and culture of duplicate quarter milk samples. Somatic cell counts were conducted on individual composite milk samples collected weekly throughout the experiment. No evidence existed of an association between somidobove administration and the incidence or duration of clinical mastitis. Furthermore, somidobove administration was not associated with an increase in new IMI or prevalence of infection by common mastitis pathogens or pathogen groups. Somatic cell counts were low in all treatment groups, but a dose-related trend was found for increased SCC in both primiparous and multiparous cows</description><identifier>ISSN: 0022-0302</identifier><identifier>EISSN: 1525-3198</identifier><identifier>DOI: 10.3168/jds.S0022-0302(94)77169-1</identifier><identifier>PMID: 7962848</identifier><identifier>CODEN: JDSCAE</identifier><language>eng</language><publisher>Savoy, IL: Am Dairy Sci Assoc</publisher><subject>Animal productions ; Animals ; BACTERIA COLIFORME ; BACTERIE COLIFORME ; Biological and medical sciences ; Cattle ; CONTEO DE CELULAS SOMATICAS ; Delayed-Action Preparations ; Female ; Fundamental and applied biological sciences. Psychology ; GLANDE MAMMAIRE ; GLANDULAS MAMARIAS ; Growth Hormone - administration & dosage ; Growth Hormone - pharmacology ; INFECCIONES LATENTES ; INFECTION LATENTE ; Injections, Subcutaneous ; LACTACION ; LACTATION ; Lactation - drug effects ; Mammary Glands, Animal - drug effects ; MAMMITE BOVINE ; MASTITIS BOVINA ; Mastitis, Bovine - epidemiology ; Mastitis, Bovine - microbiology ; METHODE D'APPLICATION ; METODOS DE APLICACION ; Milk - cytology ; NUMERATION CELLULAIRE SOMATIQUE ; NUMERO DE LACTACION ; NUMERO DE LACTATION ; Recombinant Proteins - administration & dosage ; Recombinant Proteins - pharmacology ; SOMATOTROPINA ; SOMATOTROPINE ; Staphylococcus - isolation & purification ; STAPHYLOCOCCUS AUREUS ; STREPTOCOCCUS ; Terrestrial animal productions ; VACAS LECHERAS ; VACHE LAITIERE ; Vertebrates</subject><ispartof>Journal of dairy science, 1994-08, Vol.77 (8), p.2261-2271</ispartof><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c470t-bf51595f3052a568cc598caa87443e02db29c9f4ec820bd83d4fb71c6c76705f3</citedby><cites>FETCH-LOGICAL-c470t-bf51595f3052a568cc598caa87443e02db29c9f4ec820bd83d4fb71c6c76705f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27869,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3328180$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7962848$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McClary, D.G</creatorcontrib><creatorcontrib>Green, H.B</creatorcontrib><creatorcontrib>Basson, R.P</creatorcontrib><creatorcontrib>Nickerson, S.C</creatorcontrib><title>The effects of a sustained-release recombinant bovine somatotropin (somidobove) on udder health for a full lactation</title><title>Journal of dairy science</title><addtitle>J Dairy Sci</addtitle><description>The lactational effect of somidobove (recombinant bST) injections on dairy cows in a full lactation was measured in 193 primiparous and 159 multiparous Holsteins. Experimental animals, distributed across six study sites, were administered a sustained-release formulation of somidobove by subcutaneous injection every 28 d beginning 36 to 49 DIM. Randomization at each site determined which of the following somidobove treatments cows received: 0 mg (control), 160 mg (primiparous only), 320 mg, 640 mg, or 960 mg (multiparous only). In addition to lactation response, cows on study were monitored for mastitis. Clinical mastitis was detected by examination of quarter foremilk at each milking. Milk from 300 of 352 cows was monitored for new IMI by routine collection and culture of duplicate quarter milk samples. Somatic cell counts were conducted on individual composite milk samples collected weekly throughout the experiment. No evidence existed of an association between somidobove administration and the incidence or duration of clinical mastitis. Furthermore, somidobove administration was not associated with an increase in new IMI or prevalence of infection by common mastitis pathogens or pathogen groups. Somatic cell counts were low in all treatment groups, but a dose-related trend was found for increased SCC in both primiparous and multiparous cows</description><subject>Animal productions</subject><subject>Animals</subject><subject>BACTERIA COLIFORME</subject><subject>BACTERIE COLIFORME</subject><subject>Biological and medical sciences</subject><subject>Cattle</subject><subject>CONTEO DE CELULAS SOMATICAS</subject><subject>Delayed-Action Preparations</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>GLANDE MAMMAIRE</subject><subject>GLANDULAS MAMARIAS</subject><subject>Growth Hormone - administration & dosage</subject><subject>Growth Hormone - pharmacology</subject><subject>INFECCIONES LATENTES</subject><subject>INFECTION LATENTE</subject><subject>Injections, Subcutaneous</subject><subject>LACTACION</subject><subject>LACTATION</subject><subject>Lactation - drug effects</subject><subject>Mammary Glands, Animal - drug effects</subject><subject>MAMMITE BOVINE</subject><subject>MASTITIS BOVINA</subject><subject>Mastitis, Bovine - epidemiology</subject><subject>Mastitis, Bovine - microbiology</subject><subject>METHODE D'APPLICATION</subject><subject>METODOS DE APLICACION</subject><subject>Milk - cytology</subject><subject>NUMERATION CELLULAIRE SOMATIQUE</subject><subject>NUMERO DE LACTACION</subject><subject>NUMERO DE LACTATION</subject><subject>Recombinant Proteins - administration & dosage</subject><subject>Recombinant Proteins - pharmacology</subject><subject>SOMATOTROPINA</subject><subject>SOMATOTROPINE</subject><subject>Staphylococcus - isolation & purification</subject><subject>STAPHYLOCOCCUS AUREUS</subject><subject>STREPTOCOCCUS</subject><subject>Terrestrial animal productions</subject><subject>VACAS LECHERAS</subject><subject>VACHE LAITIERE</subject><subject>Vertebrates</subject><issn>0022-0302</issn><issn>1525-3198</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>K30</sourceid><recordid>eNpdkV1rFDEYhQdR6lr9A4IQUaS9mJpkJl-XUvyCghdtr8M7maSbJTNZk4zivzfTXVbwKrycJ-ck72matwRfdYTLj7sxX91iTGmLO0wvVH8pBOGqJU-aDWGUtR1R8mmzOSHPmxc57-pIKGZnzZlQnMpebppyt7XIOmdNySg6BCgvuYCf7dgmGyxki5I1cRr8DHNBQ_xVNZTjBCWWFPd-Rhd18mOskr1EcUbLONqEthZC2SIXUzV1SwgogClQfJxfNs8chGxfHc_z5v7L57vrb-3Nj6_frz_dtKYXuLSDY4Qp5jrMKDAujWFKGgAp-r6zmI4DVUa53hpJ8TDKbuzdIIjhRnCB673z5sPBd5_iz8XmoiefjQ0BZhuXrAWXRPSKVPDdf-AuLmmub9NE1tUShQWvlDpQJsWck3V6n_wE6Y8mWK-96NqLfuxFr0vXqtePveg14c0xYRkmO55uHouo-vujDtlAcAlm4_MJ6zoqicT_frT1D9vfPlmdJwihmpI1XAgtNaV8zXt9AB1EDQ-pet3fKkZ4XWb3F-D4rNs</recordid><startdate>19940801</startdate><enddate>19940801</enddate><creator>McClary, D.G</creator><creator>Green, H.B</creator><creator>Basson, R.P</creator><creator>Nickerson, S.C</creator><general>Am Dairy Sci Assoc</general><general>American Dairy Science Association</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7WH</scope><scope>K30</scope><scope>PAAUG</scope><scope>PAWHS</scope><scope>PAWZZ</scope><scope>PAXOH</scope><scope>PBHAV</scope><scope>PBQSW</scope><scope>PBYQZ</scope><scope>PCIWU</scope><scope>PCMID</scope><scope>PCZJX</scope><scope>PDGRG</scope><scope>PDWWI</scope><scope>PETMR</scope><scope>PFVGT</scope><scope>PGXDX</scope><scope>PIHIL</scope><scope>PISVA</scope><scope>PJCTQ</scope><scope>PJTMS</scope><scope>PLCHJ</scope><scope>PMHAD</scope><scope>PNQDJ</scope><scope>POUND</scope><scope>PPLAD</scope><scope>PQAPC</scope><scope>PQCAN</scope><scope>PQCMW</scope><scope>PQEME</scope><scope>PQHKH</scope><scope>PQMID</scope><scope>PQNCT</scope><scope>PQNET</scope><scope>PQSCT</scope><scope>PQSET</scope><scope>PSVJG</scope><scope>PVMQY</scope><scope>PZGFC</scope><scope>7X8</scope></search><sort><creationdate>19940801</creationdate><title>The effects of a sustained-release recombinant bovine somatotropin (somidobove) on udder health for a full lactation</title><author>McClary, D.G ; Green, H.B ; Basson, R.P ; Nickerson, S.C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c470t-bf51595f3052a568cc598caa87443e02db29c9f4ec820bd83d4fb71c6c76705f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Animal productions</topic><topic>Animals</topic><topic>BACTERIA COLIFORME</topic><topic>BACTERIE COLIFORME</topic><topic>Biological and medical sciences</topic><topic>Cattle</topic><topic>CONTEO DE CELULAS SOMATICAS</topic><topic>Delayed-Action Preparations</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>GLANDE MAMMAIRE</topic><topic>GLANDULAS MAMARIAS</topic><topic>Growth Hormone - administration & dosage</topic><topic>Growth Hormone - pharmacology</topic><topic>INFECCIONES LATENTES</topic><topic>INFECTION LATENTE</topic><topic>Injections, Subcutaneous</topic><topic>LACTACION</topic><topic>LACTATION</topic><topic>Lactation - drug effects</topic><topic>Mammary Glands, Animal - drug effects</topic><topic>MAMMITE BOVINE</topic><topic>MASTITIS BOVINA</topic><topic>Mastitis, Bovine - epidemiology</topic><topic>Mastitis, Bovine - microbiology</topic><topic>METHODE D'APPLICATION</topic><topic>METODOS DE APLICACION</topic><topic>Milk - cytology</topic><topic>NUMERATION CELLULAIRE SOMATIQUE</topic><topic>NUMERO DE LACTACION</topic><topic>NUMERO DE LACTATION</topic><topic>Recombinant Proteins - administration & dosage</topic><topic>Recombinant Proteins - pharmacology</topic><topic>SOMATOTROPINA</topic><topic>SOMATOTROPINE</topic><topic>Staphylococcus - isolation & purification</topic><topic>STAPHYLOCOCCUS AUREUS</topic><topic>STREPTOCOCCUS</topic><topic>Terrestrial animal productions</topic><topic>VACAS LECHERAS</topic><topic>VACHE LAITIERE</topic><topic>Vertebrates</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McClary, D.G</creatorcontrib><creatorcontrib>Green, H.B</creatorcontrib><creatorcontrib>Basson, R.P</creatorcontrib><creatorcontrib>Nickerson, S.C</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Periodicals Index Online Segment 50</collection><collection>Periodicals Index Online</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - West</collection><collection>Primary Sources Access (Plan D) - International</collection><collection>Primary Sources Access & Build (Plan A) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Midwest</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Northeast</collection><collection>Primary Sources Access (Plan D) - Southeast</collection><collection>Primary Sources Access (Plan D) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Southeast</collection><collection>Primary Sources Access (Plan D) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - UK / I</collection><collection>Primary Sources Access (Plan D) - Canada</collection><collection>Primary Sources Access (Plan D) - EMEALA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - International</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - International</collection><collection>Primary Sources Access (Plan D) - West</collection><collection>Periodicals Index Online Segments 1-50</collection><collection>Primary Sources Access (Plan D) - APAC</collection><collection>Primary Sources Access (Plan D) - Midwest</collection><collection>Primary Sources Access (Plan D) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Canada</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - EMEALA</collection><collection>Primary Sources Access & Build (Plan A) - APAC</collection><collection>Primary Sources Access & Build (Plan A) - Canada</collection><collection>Primary Sources Access & Build (Plan A) - West</collection><collection>Primary Sources Access & Build (Plan A) - EMEALA</collection><collection>Primary Sources Access (Plan D) - Northeast</collection><collection>Primary Sources Access & Build (Plan A) - Midwest</collection><collection>Primary Sources Access & Build (Plan A) - North Central</collection><collection>Primary Sources Access & Build (Plan A) - Northeast</collection><collection>Primary Sources Access & Build (Plan A) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - Southeast</collection><collection>Primary Sources Access (Plan D) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - APAC</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - MEA</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of dairy science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McClary, D.G</au><au>Green, H.B</au><au>Basson, R.P</au><au>Nickerson, S.C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The effects of a sustained-release recombinant bovine somatotropin (somidobove) on udder health for a full lactation</atitle><jtitle>Journal of dairy science</jtitle><addtitle>J Dairy Sci</addtitle><date>1994-08-01</date><risdate>1994</risdate><volume>77</volume><issue>8</issue><spage>2261</spage><epage>2271</epage><pages>2261-2271</pages><issn>0022-0302</issn><eissn>1525-3198</eissn><coden>JDSCAE</coden><abstract>The lactational effect of somidobove (recombinant bST) injections on dairy cows in a full lactation was measured in 193 primiparous and 159 multiparous Holsteins. Experimental animals, distributed across six study sites, were administered a sustained-release formulation of somidobove by subcutaneous injection every 28 d beginning 36 to 49 DIM. Randomization at each site determined which of the following somidobove treatments cows received: 0 mg (control), 160 mg (primiparous only), 320 mg, 640 mg, or 960 mg (multiparous only). In addition to lactation response, cows on study were monitored for mastitis. Clinical mastitis was detected by examination of quarter foremilk at each milking. Milk from 300 of 352 cows was monitored for new IMI by routine collection and culture of duplicate quarter milk samples. Somatic cell counts were conducted on individual composite milk samples collected weekly throughout the experiment. No evidence existed of an association between somidobove administration and the incidence or duration of clinical mastitis. Furthermore, somidobove administration was not associated with an increase in new IMI or prevalence of infection by common mastitis pathogens or pathogen groups. Somatic cell counts were low in all treatment groups, but a dose-related trend was found for increased SCC in both primiparous and multiparous cows</abstract><cop>Savoy, IL</cop><pub>Am Dairy Sci Assoc</pub><pmid>7962848</pmid><doi>10.3168/jds.S0022-0302(94)77169-1</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0022-0302 |
| ispartof | Journal of dairy science, 1994-08, Vol.77 (8), p.2261-2271 |
| issn | 0022-0302 1525-3198 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_76817491 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete; Periodicals Index Online; EZB-FREE-00999 freely available EZB journals |
| subjects | Animal productions Animals BACTERIA COLIFORME BACTERIE COLIFORME Biological and medical sciences Cattle CONTEO DE CELULAS SOMATICAS Delayed-Action Preparations Female Fundamental and applied biological sciences. Psychology GLANDE MAMMAIRE GLANDULAS MAMARIAS Growth Hormone - administration & dosage Growth Hormone - pharmacology INFECCIONES LATENTES INFECTION LATENTE Injections, Subcutaneous LACTACION LACTATION Lactation - drug effects Mammary Glands, Animal - drug effects MAMMITE BOVINE MASTITIS BOVINA Mastitis, Bovine - epidemiology Mastitis, Bovine - microbiology METHODE D'APPLICATION METODOS DE APLICACION Milk - cytology NUMERATION CELLULAIRE SOMATIQUE NUMERO DE LACTACION NUMERO DE LACTATION Recombinant Proteins - administration & dosage Recombinant Proteins - pharmacology SOMATOTROPINA SOMATOTROPINE Staphylococcus - isolation & purification STAPHYLOCOCCUS AUREUS STREPTOCOCCUS Terrestrial animal productions VACAS LECHERAS VACHE LAITIERE Vertebrates |
| title | The effects of a sustained-release recombinant bovine somatotropin (somidobove) on udder health for a full lactation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T23%3A51%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20effects%20of%20a%20sustained-release%20recombinant%20bovine%20somatotropin%20(somidobove)%20on%20udder%20health%20for%20a%20full%20lactation&rft.jtitle=Journal%20of%20dairy%20science&rft.au=McClary,%20D.G&rft.date=1994-08-01&rft.volume=77&rft.issue=8&rft.spage=2261&rft.epage=2271&rft.pages=2261-2271&rft.issn=0022-0302&rft.eissn=1525-3198&rft.coden=JDSCAE&rft_id=info:doi/10.3168/jds.S0022-0302(94)77169-1&rft_dat=%3Cproquest_cross%3E76817491%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1877119076&rft_id=info:pmid/7962848&rfr_iscdi=true |